Tapewire

Nasdaq · USD

BIIB

BIOGEN INC.

Export transactions ↓
Tapewire entity
1675
SEC CIK
0000875045
Parsed reports
468

Last 12 months

Inside the activity.

1 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202612
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 01, 2016 Filed Dec 5, 2016 21:34 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
SaleCommon Stock 48 $296.53 $14,233.44
Disclosure

SEC source: 0001127602-16-069152 · form4.xml · nonDerivative · entry 2

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,360

F1 · kind: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:34 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
Tax withholdingCommon Stock 171 $295.78 $50,578.38
Disclosure

SEC source: 0001127602-16-069152 · form4.xml · nonDerivative · entry 1

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,408

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:32 UTC
COVINO GREGORY FVP, Chief Accounting Officer
Tax withholdingCommon Stock 53 $295.78 $15,676.34
Disclosure

SEC source: 0001127602-16-069149 · form4.xml · nonDerivative · entry 2

COVINO GREGORY F · CIK 0001224116 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,883.8231

Read SEC document
December 01, 2016 Filed Dec 5, 2016 21:32 UTC
COVINO GREGORY FVP, Chief Accounting Officer
GrantCommon Stock 930 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-069149 · form4.xml · nonDerivative · entry 1

COVINO GREGORY F · CIK 0001224116 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,936.8231

Read SEC document
November 08, 2016 Filed Nov 14, 2016 21:32 UTC GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-066963 · form4.xml · nonDerivative · entry 1

SHERWIN STEPHEN A · CIK 0001079462 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,905

Read SEC document
October 04, 2016 Filed Oct 5, 2016 20:24 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
SaleCommon Stock 262 $311.94 $81,728.28
Disclosure

SEC source: 0001127602-16-064339 · form4.xml · nonDerivative · entry 1

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,579

F1 · kind: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 21:02 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
SaleCommon Stock 380 $313.00 $118,940.00
Disclosure

SEC source: 0001127602-16-064102 · form4.xml · nonDerivative · entry 4

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,841

F1 · kind: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
October 01, 2016 Filed Oct 4, 2016 21:02 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
OtherRestricted Stock Unit · Derivative 2,280 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-064102 · form4.xml · derivative · entry 6

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,266

Underlying: Common Stock · 2,280 shares

Expires 2017-10-01

F3 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

Read SEC document
October 01, 2016 Filed Oct 4, 2016 21:02 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
Exercise / conversionRestricted Stock Unit · Derivative 1,982 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-16-064102 · form4.xml · derivative · entry 5

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,546

Underlying: Common Stock · 1,982 shares

Expires 2017-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

Read SEC document
October 01, 2016 Filed Oct 4, 2016 21:02 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
Tax withholdingCommon Stock 933 $313.03 $292,056.99
Disclosure

SEC source: 0001127602-16-064102 · form4.xml · nonDerivative · entry 3

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,221

Read SEC document
October 01, 2016 Filed Oct 4, 2016 21:02 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
Exercise / conversionCommon Stock 1,982 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-064102 · form4.xml · nonDerivative · entry 2

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2016 Filed Oct 4, 2016 21:02 UTC
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff
Tax withholdingCommon Stock 955 $313.03 $298,943.65
Disclosure

SEC source: 0001127602-16-064102 · form4.xml · nonDerivative · entry 1

Karaboutis Adriana · CIK 0001619963 · EVP, Tech, Bus. Sol & Corp Aff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,172

Read SEC document
September 22, 2016 Filed Sep 26, 2016 20:24 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $53.64 $0.00
Disclosure

SEC source: 0001127602-16-063177 · form4.xml · derivative · entry 5

DORSA CAROLINE · CIK 0001181174 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2020-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934

F2 · derivative.exercise_date: The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 01/04/2010.

Read SEC document
September 22, 2016 Filed Sep 26, 2016 20:24 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,570 $0.00 Strike: $53.64 $0.00
Disclosure

SEC source: 0001127602-16-063177 · form4.xml · derivative · entry 4

DORSA CAROLINE · CIK 0001181174 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,570 shares

Expires 2020-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934

Read SEC document
September 22, 2016 Filed Sep 26, 2016 20:24 UTC SaleCommon Stock 27,570 $314.00 $8,656,980.00
Disclosure

SEC source: 0001127602-16-063177 · form4.xml · nonDerivative · entry 3

DORSA CAROLINE · CIK 0001181174 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,093

F1 · kind: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934

Read SEC document
September 22, 2016 Filed Sep 26, 2016 20:24 UTC Exercise / conversionCommon Stock 25,000 $53.64 $1,341,000.00
Disclosure

SEC source: 0001127602-16-063177 · form4.xml · nonDerivative · entry 2

DORSA CAROLINE · CIK 0001181174 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,663

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934

Read SEC document
September 22, 2016 Filed Sep 26, 2016 20:24 UTC Exercise / conversionCommon Stock 2,570 $53.64 $137,854.80
Disclosure

SEC source: 0001127602-16-063177 · form4.xml · nonDerivative · entry 1

DORSA CAROLINE · CIK 0001181174 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,663

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.